Google CEO Sundar Pichai’s three-hour appearance before the US House Judiciary Committee yesterday left us largely none the wiser, besides confirming how clueless most politicians are on technology.
What we learned: Despite his best evasive efforts, Pichai confirmed that Google is working on reentering the Chinese market—referring to the controversial search project “Dragonfly.” In a series of carefully worded statements Pichai said the project was an “internal” one and that there were no plans to launch a product in China “right now.” He also expressed support for a national data protection law in the US, describing the European Union’s General Data Protection Regulation as a “well-thought-out, well-crafted piece of legislation.”
Political theater: There were several contenders for a “peak stupid” prize. Iowa representative Steve King appeared to be unaware that Google does not manufacture iPhones. Another asked Pichai to explain why a Google search for the word “idiot” turns up pictures of Donald Trump, part of a (futile) line of questioning by Republicans convinced search results are biased against them. Texas representative Ted Poe demanded to know if Google was able to tell if he walked from one side of the room to another. “Not by default,” replied Pichai, explaining that it would depend which apps had been installed. Credit, however, to Rhode Island’s David Cicilline, who got closest to getting some answers from Pichai on Dragonfly.
Next time: It’d be good to hear some more questions on YouTube’s role in spreading conspiracy theories, Google’s vast data collection machinery, its security practices (a second Google+ hack came to light this week), and its anti-competitive behavior.
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
The dark secret behind those cute AI-generated animal images
Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.